Synthorx, Inc. News
France's Sanofi to Buy Cancer-Drug Specialist Synthorx for $68-Share, or $2.5 Billion
The deal price is nearly triple Synthorx's Friday closing price above $25. One of Sanofi's goals is to build its oncology franchise, the CEO said in a statement.
Merck & Co. Acquires Cancer Drug Specialist ArQule For $2.7 Billion
ArQule shares surge after the cancer drug specialists agreed to a $2.7 billion takeover bid from Merck & Co.
Jim Cramer Reacts to Thor Industries Earnings
Jim Cramer said millennials played a big part in Thor Industries' colossal earnings beat.
Thor Industries Drops Double Digits on Mixed Earnings
Thor Industries beat FactSet's expectations but missed Zacks bottom-line estimates.
Oil, Yellen and world gdp growth: How to trade the week ahead
Conditions seem ripe for continued upward momentum in stocks, as long as the Federal Reserve or unexpected shocks don't get in the way.
Breaking News
Robinhood Stock Surges, Then Halted, Amid Reports of FTX Takeover Interest
Sam Bankman-Fried's FTX is looking for a path to buy online brokerage group Robinhood, Bloomberg reported Monday.
General Electric Stock Gains As CEO Larry Culp Takes Over Aviation Division
"There is tremendous opportunity in aviation over the coming years, and the Board and I decided it is the right time for me to take on this expanded role," said GE CEO Larry Culp.
Feds Could Stop Trump SPAC Deal
An investigation by a federal grand jury could halt the proposed SPAC deal with Trump's social media company.
McDonald's Brings Back a Classic Menu Item (with a Catch)
You never know what the fast-food chain might bring back or create a new version of.